Cubist Systematic Strategies’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$727K Sell
132,194
-68,254
-34% -$334K ﹤0.01% 2100
2025
Q2
$1.04M Sell
200,448
-107,885
-35% -$646K ﹤0.01% 1934
2025
Q1
$2.05M Buy
+308,333
New +$2.34M 0.01% 1403
2024
Q4
Sell
-422,179
Closed -$2.96M 3304
2024
Q3
$2.96M Buy
+422,179
New +$2.54M 0.02% 1190
2024
Q2
Sell
-68,111
Closed -$420K 3544
2024
Q1
$420K Buy
+68,111
New +$459K ﹤0.01% 2715
2023
Q4
Sell
-16,743
Closed -$115K 3856
2023
Q3
$115K Buy
+16,743
New +$136K ﹤0.01% 2916
2022
Q3
Sell
-7,585
Closed -$42K 4587
2022
Q2
$42K Sell
7,585
-11,077
-59% -$84.8K ﹤0.01% 4123
2022
Q1
$189K Buy
18,662
+180
+1% +$1.58K ﹤0.01% 3070
2021
Q4
$176K Buy
+18,482
New +$196K ﹤0.01% 3070
2021
Q3
Sell
-700
Closed -$20K 3070
2021
Q2
$20K Buy
+700
New +$18.5K ﹤0.01% 2848

Other funds holding LFST

Cubist Systematic Strategies's LFST Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Lifestance Health (LFST) stake by 34% in Q3 2025, selling an estimated $334K and leaving 132,194 shares worth $727K. The position accounts for ﹤0.01% of the portfolio, ranked #2100.

Cubist Systematic Strategies first reported a position in LFST in Q2 2021 and has held it in 10 quarters since. The position peaked at $2.96M in Q3 2024. 210 funds tracked by Wall St. Rank hold LFST as of Q3 2025.

  • Cubist Systematic Strategies held 132,194 shares of Lifestance Health worth $727K as of Q3 2025.
  • Cubist Systematic Strategies sold 68,254 Lifestance Health shares in Q3 2025, an estimated $334K.
  • Lifestance Health made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2100 holding.
  • Cubist Systematic Strategies first reported a position in Lifestance Health in Q2 2021 and has held it in 10 quarters since.
  • Cubist Systematic Strategies's Lifestance Health position peaked at $2.96M in Q3 2024.
  • 210 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.